Certara (NASDAQ:CERT) Research Coverage Started at JMP Securities

JMP Securities began coverage on shares of Certara (NASDAQ:CERT) in a note issued to investors on Thursday, MarketBeat Ratings reports. The brokerage set a “market perform” rating on the stock.

A number of other equities research analysts also recently commented on the company. UBS Group increased their price objective on Certara from $17.00 to $20.00 and gave the company a “neutral” rating in a research report on Friday, March 1st. Barclays upped their price target on shares of Certara from $16.00 to $18.00 and gave the stock an “equal weight” rating in a research note on Thursday, January 25th. Leerink Partnrs reaffirmed a “market perform” rating on shares of Certara in a research note on Monday, February 26th. SVB Leerink initiated coverage on shares of Certara in a research report on Monday, February 26th. They set a “market perform” rating and a $19.00 target price on the stock. Finally, Jefferies Financial Group increased their target price on shares of Certara from $14.00 to $15.50 and gave the stock a “hold” rating in a research report on Friday, March 1st. Eight analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $19.64.

Certara Stock Up 2.3 %

Shares of Certara stock opened at $18.15 on Thursday. The firm has a market cap of $2.90 billion, a P/E ratio of -51.86, a P/E/G ratio of 1.74 and a beta of 1.63. The business has a 50-day moving average price of $17.63 and a 200 day moving average price of $15.93. Certara has a fifty-two week low of $11.81 and a fifty-two week high of $24.96. The company has a quick ratio of 2.62, a current ratio of 2.62 and a debt-to-equity ratio of 0.28.

Certara (NASDAQ:CERT) last posted its earnings results on Thursday, February 29th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.04). The company had revenue of $88.01 million for the quarter, compared to the consensus estimate of $86.80 million. Certara had a negative net margin of 15.62% and a positive return on equity of 4.33%. On average, sell-side analysts forecast that Certara will post 0.29 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Certara news, SVP Richard M. Traynor sold 6,000 shares of the firm’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $18.00, for a total transaction of $108,000.00. Following the completion of the transaction, the senior vice president now owns 165,368 shares in the company, valued at $2,976,624. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, SVP Richard M. Traynor sold 6,000 shares of the firm’s stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $18.00, for a total transaction of $108,000.00. Following the completion of the sale, the senior vice president now owns 165,368 shares of the company’s stock, valued at $2,976,624. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP Richard M. Traynor sold 3,000 shares of the firm’s stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $18.00, for a total transaction of $54,000.00. Following the sale, the senior vice president now directly owns 173,524 shares of the company’s stock, valued at approximately $3,123,432. The disclosure for this sale can be found here. Insiders sold a total of 23,427 shares of company stock worth $405,095 over the last quarter. Company insiders own 2.60% of the company’s stock.

Institutional Trading of Certara

Several hedge funds have recently modified their holdings of CERT. BlackRock Inc. increased its holdings in shares of Certara by 157.8% in the first quarter. BlackRock Inc. now owns 14,796,486 shares of the company’s stock valued at $356,743,000 after purchasing an additional 9,055,874 shares in the last quarter. Vanguard Group Inc. increased its holdings in shares of Certara by 6.2% in the third quarter. Vanguard Group Inc. now owns 10,652,509 shares of the company’s stock valued at $141,466,000 after purchasing an additional 626,267 shares in the last quarter. Mubadala Investment Co PJSC acquired a new stake in shares of Certara in the fourth quarter valued at approximately $169,135,000. William Blair Investment Management LLC increased its holdings in shares of Certara by 1.1% in the third quarter. William Blair Investment Management LLC now owns 7,150,914 shares of the company’s stock valued at $103,974,000 after purchasing an additional 77,805 shares in the last quarter. Finally, Clearbridge Investments LLC increased its holdings in shares of Certara by 0.3% in the fourth quarter. Clearbridge Investments LLC now owns 4,140,349 shares of the company’s stock valued at $72,829,000 after purchasing an additional 10,429 shares in the last quarter. Institutional investors and hedge funds own 73.96% of the company’s stock.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.